Published in Learn Mem on April 25, 2008
Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. Cell (2012) 1.75
The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium (2010) 1.40
Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. Proc Natl Acad Sci U S A (2011) 1.25
Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2011) 1.15
PCB-95 modulates the calcium-dependent signaling pathway responsible for activity-dependent dendritic growth. Environ Health Perspect (2012) 1.10
The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease. Channels (Austin) (2014) 0.87
Structural basis of conformational transitions in the active site and 80's loop in the FK506-binding protein FKBP12. Biochem J (2014) 0.80
Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. Hum Mol Genet (2015) 0.78
Crystal structure and conformational flexibility of the unligated FK506-binding protein FKBP12.6. Acta Crystallogr D Biol Crystallogr (2014) 0.77
Comparative characterization of two intracellular Ca²⁺-release channels from the red flour beetle, Tribolium castaneum. Sci Rep (2014) 0.76
Mecp2 Mediates Experience-Dependent Transcriptional Upregulation of Ryanodine Receptor Type-3. Front Mol Neurosci (2017) 0.75
RyR2-Mediated Ca(2+) Release and Mitochondrial ROS Generation Partake in the Synaptic Dysfunction Caused by Amyloid β Peptide Oligomers. Front Mol Neurosci (2017) 0.75
Aging Impairs Hippocampal- Dependent Recognition Memory and LTP and Prevents the Associated RyR Up-regulation. Front Aging Neurosci (2017) 0.75
The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J Cell Biol (1995) 2.87
Calcium stores regulate the polarity and input specificity of synaptic modification. Nature (2000) 2.84
The ryanodine receptor/Ca2+ release channel. J Biol Chem (1993) 2.50
Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci (2002) 2.33
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci (2006) 2.32
Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem (2007) 2.14
Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. EMBO J (1998) 1.88
Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science (1984) 1.80
Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain. J Neurosci (1993) 1.76
Elevated postsynaptic [Ca2+]i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J Neurosci (2001) 1.67
Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner. J Neurophysiol (1992) 1.56
Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. EMBO J (1995) 1.46
Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning. EMBO J (1999) 1.42
An improved one-trial passive avoidance learning situation. Psychol Rep (1967) 1.37
Aging changes in voltage-gated calcium currents in hippocampal CA1 neurons. J Neurosci (1996) 1.32
Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3. Neuron (1999) 1.32
Calcium dysregulation in neuronal aging and Alzheimer's disease: history and new directions. Cell Calcium (1999) 1.29
The calcium rationale in aging and Alzheimer's disease. Evidence from an animal model of normal aging. Ann N Y Acad Sci (1994) 1.28
Neuronal Ca2+ stores: activation and function. Trends Neurosci (1995) 1.26
Enhanced long-term potentiation during aging is masked by processes involving intracellular calcium stores. J Neurophysiol (2004) 1.24
Calcium and the aging nervous system. Neurobiol Aging (1987) 1.22
Calcium-dependent afterhyperpolarization and learning in young and aging hippocampus. Life Sci (1996) 1.18
'Increased calcium-current' hypothesis of brain aging. Neurobiol Aging (1987) 1.17
The role of calcium regulation in brain aging: reexamination of a hypothesis. Aging (Milano) (1989) 1.13
Biophysical alterations of hippocampal pyramidal neurons in learning, ageing and Alzheimer's disease. Ageing Res Rev (2004) 1.10
Enhancement of Ca2+ release channel activity by phosphorylation of the skeletal muscle ryanodine receptor. FEBS Lett (1993) 1.06
Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors. J Physiol (1997) 1.06
Effects of ryanodine on the spike after-hyperpolarization in sympathetic neurones of the rat superior cervical ganglion. Pflugers Arch (1989) 1.05
The effects of high Mg2+-to-Ca2+ ratios on frequency potentiation in hippocampal slices of young and aged rats. J Neurophysiol (1986) 1.04
Potentiation of a slow Ca(2+)-dependent K+ current by intracellular Ca2+ chelators in hippocampal CA1 neurons of rat brain slices. J Neurophysiol (1995) 1.03
Spatial learning induced changes in expression of the ryanodine type II receptor in the rat hippocampus. FASEB J (2000) 1.03
Molecular genetics of ryanodine receptors Ca2+-release channels. Cell Calcium (2003) 1.03
Ca2+-induced Ca2+ release mediates a slow post-spike hyperpolarization in rabbit vagal afferent neurons. J Neurophysiol (1998) 0.98
Cyclic ADP-ribose and calcium-induced calcium release regulate neurotransmitter release at a cholinergic synapse of Aplysia. J Physiol (1998) 0.98
Caloric restriction prevents aging-associated changes in spike-mediated Ca2+ accumulation and the slow afterhyperpolarization in hippocampal CA1 pyramidal neurons. Neuroscience (2005) 0.97
Aging-related prolongation of calcium spike duration in rat hippocampal slice neurons. Brain Res (1990) 0.95
Intracellular Ca(2+) and Ca(2+)/calmodulin-dependent kinase II mediate acute potentiation of neurotransmitter release by neurotrophin-3. J Cell Biol (2000) 0.94
Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus. Brain Res Mol Brain Res (2000) 0.92
A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen. Neuropharmacology (1985) 0.89
Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin: effect on protein synthesis. J Neurochem (1996) 0.88
Neuronal ageing from an intraneuronal perspective: roles of endoplasmic reticulum and mitochondria. Cell Calcium (2003) 0.87
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. Neuropharmacology (2005) 0.85
Aging-related increase in hippocampal calcium channels. Life Sci (1996) 0.85
Pharmaco-behavioural evidence indicating a complex role for ryanodine receptor calcium release channels in memory processing for a passive avoidance task. Neurobiol Learn Mem (2006) 0.85
Alterations in the properties of hippocampal pyramidal neurons in the aged rat. Neuroscience (1992) 0.83
Control of IsAHP in mouse hippocampus CA1 pyramidal neurons by RyR3-mediated calcium-induced calcium release. Pflugers Arch (2007) 0.83
Distinct intracellular calcium profiles following influx through N- versus L-type calcium channels: role of Ca2+-induced Ca2+ release. J Neurophysiol (2004) 0.82
Fast axonal transport is modulated by altering trans-axolemmal calcium flux. Cell Calcium (1992) 0.81
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. Neuroscience (2003) 0.81
Alpha-2 agonists induce amnesia through activation of the Gi-protein signalling pathway. Neuroscience (2004) 0.80
Role of intracellular calcium in acute thermal pain perception. Neuropharmacology (2004) 0.80
Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis (2006) 1.65
Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc Natl Acad Sci U S A (2004) 1.47
Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway. Proc Natl Acad Sci U S A (2005) 1.45
Acycloguanosyl 5'-thymidyltriphosphate, a thymidine analogue prodrug activated by telomerase, reduces pancreatic tumor growth in mice. Gastroenterology (2010) 1.44
Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol (2007) 1.42
Solution structure of human beta-parvalbumin and structural comparison with its paralog alpha-parvalbumin and with their rat orthologs. Biochemistry (2004) 1.41
Menthol: a natural analgesic compound. Neurosci Lett (2002) 1.32
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. PLoS One (2011) 1.29
Widespread uncoupling between transcriptome and translatome variations after a stimulus in mammalian cells. BMC Genomics (2012) 1.12
Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry (2004) 1.10
Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal (2006) 1.08
A role for the ELAV RNA-binding proteins in neural stem cells: stabilization of Msi1 mRNA. J Cell Sci (2006) 1.07
Post-transcriptional regulation of neuro-oncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV. J Biol Chem (2008) 1.07
Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J Pain (2013) 1.05
Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain (2012) 1.02
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma. Hum Mol Genet (2010) 1.01
Signaling pathway of morphine induced acute thermal hyperalgesia in mice. Pain (2006) 1.01
The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. J Clin Endocrinol Metab (2004) 0.99
Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res (2009) 0.98
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genet (2013) 0.98
Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. Mol Cancer (2012) 0.98
[(3-Chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents. J Med Chem (2003) 0.97
A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain. Sci Rep (2013) 0.95
Effects of dietary extra-virgin olive oil on behaviour and brain biochemical parameters in ageing rats. Br J Nutr (2010) 0.93
Protective effect of alpha7 nAChR: behavioural and morphological features on neuropathy. Pain (2010) 0.92
Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor. J Neurosci Res (2009) 0.91
Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities. Bioorg Med Chem (2002) 0.91
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action. J Med Chem (2006) 0.91
Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm (2007) 0.91
Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Liposome Res (2009) 0.90
nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing. J Alzheimers Dis (2009) 0.90
4-amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action. J Med Chem (2007) 0.89
Ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and safe antianxiety agent. J Med Chem (2008) 0.89
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. Behav Brain Res (2004) 0.89
Pleiotropic effect of histamine H4 receptor modulation in the central nervous system. Neuropharmacology (2013) 0.88
Low dose native type II collagen prevents pain in a rat osteoarthritis model. BMC Musculoskelet Disord (2013) 0.88
A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages. ACS Nano (2014) 0.88
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists. Bioorg Med Chem Lett (2007) 0.88
Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats. Neuropharmacology (2002) 0.88
Calcium-regulated GTPase activity in the calcium-binding protein calexcitin. Comp Biochem Physiol B Biochem Mol Biol (2003) 0.87
Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal nociception. J Neurochem (2007) 0.87
Alpha2-agonists as analgesic agents. Med Res Rev (2009) 0.87
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. Clin Sci (Lond) (2012) 0.87
Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK, and P38 MAPK phosphorylation. Pain (2015) 0.86
Hyper conserved elements in vertebrate mRNA 3'-UTRs reveal a translational network of RNA-binding proteins controlled by HuR. Nucleic Acids Res (2013) 0.86
Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia. J Neurochem (2009) 0.86
Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. Eur J Pharm Sci (2011) 0.86
Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation. Int J Neuropsychopharmacol (2011) 0.86
A prokaryotic superoxide dismutase paralog lacking two Cu ligands: from largely unstructured in solution to ordered in the crystal. Proc Natl Acad Sci U S A (2005) 0.85
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. Neuropharmacology (2004) 0.85
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. Neuropharmacology (2005) 0.85
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms. Recent Pat CNS Drug Discov (2011) 0.85
Paramagnetism-based refinement strategy for the solution structure of human alpha-parvalbumin. Biochemistry (2004) 0.84
Antisense knockdown of the Shaker-like Kv1.1 gene abolishes the central stimulatory effects of amphetamines in mice and rats. Neuropsychopharmacology (2003) 0.84
Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies. J Med Chem (2006) 0.84
Dopamine is necessary to endogenous morphine formation in mammalian brain in vivo. J Neurochem (2008) 0.83
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. Neuropharmacology (2004) 0.83
Prochlorperazine induces central antinociception mediated by the muscarinic system. Pharmacol Res (2004) 0.82
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. J Med Chem (2009) 0.82
Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats. Mediators Inflamm (2013) 0.82
Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage. Bioorg Med Chem (2007) 0.82
Identification of two novel mutations and of a novel critical region in the KRIT1 gene. Neurogenetics (2006) 0.81
Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain Kv1.6 channel subtype. Br J Pharmacol (2004) 0.81
Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol Biochem Behav (2002) 0.81
Activation of JNK pathway in spinal astrocytes contributes to acute ultra-low-dose morphine thermal hyperalgesia. Pain (2015) 0.81
Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. J Pineal Res (2005) 0.81
Inhibition of the PKCγ-ε pathway relieves from meningeal nociception in an animal model: an innovative perspective for migraine therapy? Neurotherapeutics (2013) 0.81
Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs. Curr Pharm Des (2002) 0.81
Selective modulation of the PKCɛ/p38MAP kinase signalling pathway for the antidepressant-like activity of amitriptyline. Neuropharmacology (2011) 0.80
Role of intracellular calcium in acute thermal pain perception. Neuropharmacology (2004) 0.80
Segmental chromosome aberrations converge on overexpression of mitotic spindle regulatory genes in high-risk neuroblastoma. Genes Chromosomes Cancer (2012) 0.80
Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anesthetic efficacy. J Liposome Res (2010) 0.80
Tuning the engine: an introduction to resources on post-transcriptional regulation of gene expression. RNA Biol (2012) 0.80
Methylamine: a new endogenous modulator of neuron firing? Med Sci Monit (2005) 0.80
Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine. Pharmacol Res (2002) 0.80
The phospholipase C-IP3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology (2002) 0.79
Synergistic effect of L-Carnosine and EGCG in the prevention of physiological brain aging. Curr Pharm Des (2013) 0.79
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression. Psychopharmacology (Berl) (2011) 0.79
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. Neuropsychopharmacology (2002) 0.79
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity. Bioorg Med Chem (2013) 0.79
Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets. Psychopharmacology (Berl) (2012) 0.79